ADA Technologies to build up home lithiummonitor for patients with bipolar disorder ADA Technologies, Inc. received a $189,886 grant from the National Institute of Mental Health to develop a home lithiummonitor for make use of by patients with bipolar disorder. The testing tool allows reliable, routine at-house monitoring of blood lithium concentrations, enabling people with bipolar disorder to easily and successfully manage their care Get more information . Effective treatment of bipolar disorder, an inherited disease that impacts 5.7 million adult Americans capsules right now approved by FDA to take care of schizophrenia, bipolar disorder in adultsStudy explores diabetes screening for individuals with severe mental illnessGeneral psychiatric support warranted in MS patientsTesting lithium focus in blood is incredibly challenging due to the interference of sodium.D., ADA senior scientist and principal investigator on the task..
The FDA has provided ACT clearance to proceed with a Stage II trial, which can be expected to start in the first half of 2011. The open-enrollment trial will target patients who aren’t qualified to receive angioplasty or coronary artery bypass operation and have a poor quality of life despite the help of a pacemaker or defibrillator gadget.. ACT updates myoblast program for heart failure treatment Advanced Cell Technology , a innovator in neuro-scientific regenerative medicine, today on the status of it is myoblast plan provided an update. The program has effectively and safely completed Phase I human medical trials in a lot more than forty sufferers in over four independent research.